Company · CIK 0001810182 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ALX ONCOLOGY HOLDINGS INC · ALXO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 SForm 4 → | Aug 18, 5:51 pm EDT | Jason LettmannCHIEF EXECUTIVE OFFICER, Director | 2,230 | $1.93 | $4,304 | 294,379 | −0.75% | |
| Aug 17, 2026 SForm 4 → | Aug 18, 5:50 pm EDT | Shelly WongSVP, FINANCE AND CAO | 573 | $1.93 | $1,106 | 87,828 | −0.65% | |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Shelly WongSVP, FINANCE AND CAO | 1,404 | $2.04 | $2,864 | 88,401 | −1.56% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.